Petros C Karakousis

17PUBLICATIONS
44CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesTime series and spatial modellingGene and molecular therapyHealth policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 03, 2026
Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis.

Nicholas Schumann, Farah Shamma, Cory L Brooks

|May 21, 2025
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19.

Leon L Hsieh, Elizabeth A Thompson, Nirvani P Jairam

|May 15, 2025
A Pivotal Trial in the Decline of Tuberculosis Sanatoria.

Petros C Karakousis, Graham Mooney

|Apr 23, 2025
Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models.

Jacob Meza, Elizabeth Glass, Avinaash K Sandhu

|Mar 26, 2025
When Infection Control Practices and Democracy Collide: Reply to Paladino and Riva.

Olivia S Kates, Petros C Karakousis

|Nov 19, 2024
Pharmacologic Inhibition of Macrophage Triglyceride Biosynthesis Pathways Does Not Improve Mycobacterium tuberculosis Control in Infected Mice.

Jennie Ruelas Castillo, Valentina Guerrini, Darla Quijada

Pageof 3

Frequent Collaborators

4 joint publications

Joel S Bader

3 joint publications

Styliani Karanika

2 joint publications

Noton K Dutta

2 joint publications

William M Matern